The Business APAC Cloud Disruptors of 2019 Final File_Cloud | Page 35

“Using PRISM companies can proactively prepare for a new product
launch using past insights and gain a broad understanding of patterns of
customer medical inquiries, consumer sentiment, product performance,
market access, content usage and many other valuable information after
a new medical product is launched in different regions. Contact centers
will gain the advantage to plan and optimize their operations with
forecasting capabilities.”, added Satya Sagi.
Fully Managed Drug Safety & Clinical Development Cloud
Solutions for Emerging BioPharma
For drug safety and signal management, Techsol provides the
AccelSafety cloud solution powered by the Oracle Argus Safety
application to enable unified collection, medical assessment, and
regulatory reporting of clinical and post-marketing safety
surveillance data. Using ‘CaseIRT’ cloud, Pharma companies can
leverage automated intake, receipt, and triaging of adverse events
using artificial intelligence methodologies such as machine
learning & NLP.
Satya Sagi
CEO & Founder
Saad Rahman
Director of Product
Management
Our mission is to team up
with Pharma Companies &
Research Organizations to
optimize science with
advanced cloud
technology solutions
and revolutionize how new
medical treatments are
discovered, developed and
delivered to people around
the world.
businessapac.com
Additionally, Techsol offers its proprietary “PVSentinel” cloud
solution for enabling proactive pharmacovigilance operations
oversight and compliance governance. Pharm companies can
streamline, track and report the outcomes of cross-functional
activities managed by different vendors, partners and affiliates. Other
solutions include ‘AccelClinical’ for Clinical Data Management and
‘AccelCTMS’ for Clinical Trial Management which are powered by
Oracle Health Sciences applications.
Techsol’s Current and Future Plans
As per Satya Sagi, the next set of cloud-based emerging technologies
that will revolutionize the pharma industry are Artificial Intelligence &
Machine Learning, Internet of Things (IoT), 3D Printing, Virtual
Clinical Trials and Precision Medicine. These in turn are fueled by Big
Data to derive the maximum value for molecule discovery, care
delivery and patient engagement.
Understanding current market trends, innovation landscape, staying
updated on regional regulations, observing the pace of technology
adoption and gaining competitive intelligence is of paramount
importance to win against the odds. The challenge for any new tech
innovation in this arena will continue to revolve around quality,
compliance and risk. Another key element of is to develop and offer
solutions that will continue to scale and grow for clients over the years.
With a lead in the APAC market, Techsol has established its corporate
headquarters in the United States to serve clients in the North American
region and has strategic direction planned for the European market.
Techsol’s primary goal is to launch new innovations by leveraging new
technology advancements such as AI, machine learning and NLP. in
addition to their current products and continue to expand their
opportunities in the services business unit.
Currently, Techsol is working with seven of ten top pharma companies
in India and is running projects in Thailand, Singapore, Australia
including the South Korean drug safety agency.
35
April 2019